Therefore, we hypothesized that PTHrP might be one of the target proteins of TP, inhibiting the abnormal RANKL expression in osteoblasts in the tumor environment, which served to indirectly inhibit osteoclastogenesis and alleviate the progression of breast cancer bone metastasis. Here, TNFSF11 is linked to breast cancer.